Kelly CRISPR & Gene Editing Technology ETF (XDNA) News Today $7.38 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesOptions ChainRatingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right nowOctober 2, 2024 | yahoo.comK-12 Genome Editing at Only $2 a PopSeptember 27, 2024 | yahoo.comVertex Stock: Came For CF Drugs, Staying For Gene TherapyAugust 2, 2024 | seekingalpha.comCRISPR can treat common form of inherited blindness, early data hintMay 15, 2024 | msn.comCRISPR Technology Takes Center Stage at SXSW 2024 for the First TimeMarch 9, 2024 | markets.businessinsider.comIntellia Collaborates With ReCode To Develop Gene Therapy For Cystic FibrosisFebruary 15, 2024 | markets.businessinsider.comHere's Why CRISPR Therapeutics Stock Rose 54% Last YearJanuary 15, 2024 | msn.comGene editing is now a medical realityDecember 8, 2023 | news.yahoo.comFDA approves first use of CRISPR gene editing to treat sickle cell diseaseDecember 8, 2023 | news.yahoo.comFDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood DisorderDecember 8, 2023 | markets.businessinsider.comGene Editing Will Change Medicine—and Maybe Health Investing TooNovember 24, 2023 | msn.comIs CRISPR Therapeutics the Best Gene-Editing Stock?November 22, 2023 | msn.com3 Biotech Stocks That Are Betting on the Future of Gene EditingNovember 9, 2023 | markets.businessinsider.comCRISPR gene editing could kill HIV. But is it a cure?October 30, 2023 | msn.comCantor Fitzgerald Downgrades CRISPR Therapeutics (CRSP)October 17, 2023 | msn.comCRISPR Market is Expected to Reach $7.1 Billion | MarketsandMarkets.August 3, 2023 | finance.yahoo.comGene Editing Market worth $10.6 billion | MarketsandMarketsJuly 16, 2023 | benzinga.comCRISPR Therapeutics: A Galaxy's Worth of Deep ValueMay 31, 2023 | msn.comGlobal Gene Editing Technologies Market to Reach $16.37 Billion by 2032 - Exclusive DeepTech M-A-P™ Analysis by BIS ResearchMay 19, 2023 | benzinga.comKelly CRISPR & Gene Editing Technology ETF (XDNA)May 14, 2023 | uk.investing.comGuide to the First Ever FDA CRISPR Approval Expected this Year by CRISPR & Vertex (XDNA ETF Companies)April 21, 2023 | nasdaq.comMegatrends: Gene Therapy and EditingApril 17, 2023 | money.usnews.comGene Editing Tools Market Outlook, Share, Prominent Players, Size, Growth, and Forecast 2023 to 2031March 21, 2023 | marketwatch.comHow human gene editing is moving on after the CRISPR baby scandalMarch 11, 2023 | cnn.comGlobal Advances in Gene Editing Technologies in Healthcare Market Report 2023: CRISPR, ZFNs, and TALENs have Revolutionized the Gene Editing FieldFebruary 11, 2023 | benzinga.comWhat is CRISPR? What to know about the transformative gene-editing tool.February 11, 2023 | usatoday.comHow Gene Editing Could Help Solve the Problem of Poor CholesterolDecember 28, 2022 | time.comGene Editing Market Size And Opportunities for New Players, Forecast from 2022 To 2028 with Top Countries DataDecember 20, 2022 | marketwatch.comGene Editing Market Size In 2022 : Future Scope, Demands and Projected Technology Type Growths to 2028 | 93 Report PagesNovember 24, 2022 | marketwatch.comGene Kelly Admitted to Terrorizing This Co-Star: 'Surprised She Still Speaks to Me.'September 24, 2022 | msn.comGenome Editing Market to Hit $21.36 Billion by 2030, With a CAGR of 17.33% Asserts Strategic Market ResearchSeptember 12, 2022 | finance.yahoo.comGenome Editing Technologies Market Report 2022-2032September 8, 2022 | finance.yahoo.comGenome Editing Market Size to Grow USD 6739.8 Million by 2028 at a CAGR of 9.3% | Valuates ReportsSeptember 5, 2022 | benzinga.comGlobal Genome Editing Market Report 2022: Continuous Technological Advancements in Gene-Editing Tools Driving GrowthAugust 29, 2022 | finance.yahoo.comA Cellular Engineering Breakthrough: High-Yield CRISPR Without Viral VectorsAugust 25, 2022 | benzinga.comUnlocking the Potential of Gene EditingAugust 24, 2022 | nasdaq.comChinese scientists develop new ‘controllable and reversible’ gene-editing techniqueAugust 17, 2022 | msn.comCrispr: My Long-Term 'Wait And Watch' Punt On The Future Of Gene EditingAugust 8, 2022 | seekingalpha.comSNIPR Biome Granted New US Patent Covering Lytic CRISPR PhageAugust 2, 2022 | benzinga.com3 Sectors You Might Have Missed with Upside (XDNA)Thematic ETFs are poised to become more important vehicles for accessing subindustries in very targeted ways that are not possible with broad sector funds.July 28, 2022 | marketbeat.comGene Editing Market Is Expected to Reach $7.4 Billion by 2031, Claims AMRJuly 11, 2022 | finance.yahoo.comGene Editing Market : Industry Trends, Size, Growth Insight, Share, Competitive Analysis, Statistics, Regional, And Global Industry Forecast to 2027June 25, 2022 | marketwatch.comWorldwide Genome Editing Industry to 2027 - North America to Dominate the Global MarketJune 24, 2022 | benzinga.comNovartis Follows Eli Lilly With $1.4 Billion Gene-Editing PactJune 22, 2022 | msn.comAdvances for India as foundational CRISPR/Cas9 gene editing patent grantedJune 13, 2022 | benzinga.com Get Kelly CRISPR & Gene Editing Technology ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for XDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address “Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late. XDNA Media Mentions By Week XDNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XDNA News Sentiment▼0.000.92▲Average News Sentiment XDNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XDNA Articles This Week▼00▲XDNA Articles Average Week Get Kelly CRISPR & Gene Editing Technology ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for XDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RAYS News LITP News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XDNA) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kelly CRISPR & Gene Editing Technology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Kelly CRISPR & Gene Editing Technology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XDNA Stock Alerts